As monkeypox global cases surpass 6,000, the World Health Organization will reassess whether the outbreak constitutes a public health emergency of international concern.
Public Health
The use of sabizabulin, a cancer drug, reduced the risk of death by 55 percent in patients hospitalized with COVID-19, a small study published July 6 in the New England Journal of Medicine found.
The omicron subvariant BA.5 is quickly gaining prevalence in the U.S. and now accounts for nearly 54 percent of all cases, according to the CDC's latest variant proportion update for the week ending July 2.
In 2021, COVID-19 was the leading cause of death for 45- to 54-year-olds, with 16.8 percent of deaths being attributed to the disease, a study published in JAMA Internal Medicine on July 5 found. In 2020, COVID-19 was the fourth…
New York City health officials ended its COVID-19 alert system, which informed residents of changes in transmission levels, Bloomberg reported July 1.
Advertisement
COVID-19 hospitalizations and deaths will remain stable through late July while cases will continue to rise, national disease modeling suggests.
As of July 1, 460 cases of monkeypox have been confirmed across 31 states and Washington, D.C. That's up from 351 cases as of June 29.
As the number of reported COVID-19 cases teeters at about 100,000 each day, health experts warn there isn't an easy fix but pointed to two tools aimed at tackling the pandemic: improving nationwide vaccination rates and the potential of omicron-targeted…
The U.S. will deploy 296,000 doses of Jynneos monkeypox vaccine — the preferred vaccine — over the coming weeks and is expanding eligibility for vaccination.
Global health officials have identified at least 920 probable cases of acute hepatitis of unknown origin among children in 33 countries, the World Health Organization said June 24.